Mark Corbett

30.8k total citations
43 papers, 1.4k citations indexed

About

Mark Corbett is a scholar working on Economics and Econometrics, Pharmacology and Oncology. According to data from OpenAlex, Mark Corbett has authored 43 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Economics and Econometrics, 9 papers in Pharmacology and 8 papers in Oncology. Recurrent topics in Mark Corbett's work include Health Systems, Economic Evaluations, Quality of Life (12 papers), Musculoskeletal pain and rehabilitation (4 papers) and Meta-analysis and systematic reviews (4 papers). Mark Corbett is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (12 papers), Musculoskeletal pain and rehabilitation (4 papers) and Meta-analysis and systematic reviews (4 papers). Mark Corbett collaborates with scholars based in United Kingdom, United States and Thailand. Mark Corbett's co-authors include Nerys Woolacott, Julian P. T. Higgins, Stephen Rice, Stephen Palmer, Melissa Harden, Alison Eastwood, C.A. Saxton, Adam Young, B.J. Wagg and I. M. Waite and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Clinical Epidemiology.

In The Last Decade

Mark Corbett

37 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Corbett United Kingdom 21 224 202 197 193 189 43 1.4k
Stephen Rice United Kingdom 23 180 0.8× 199 1.0× 297 1.5× 168 0.9× 635 3.4× 75 2.3k
Sun‐Young Jung South Korea 23 99 0.4× 175 0.9× 258 1.3× 152 0.8× 165 0.9× 127 1.6k
Marja Blom Finland 27 131 0.6× 465 2.3× 158 0.8× 311 1.6× 562 3.0× 55 2.2k
Alan Oglesby United States 25 101 0.5× 168 0.8× 239 1.2× 372 1.9× 371 2.0× 55 2.2k
Juan Víctor Ariel Franco Argentina 23 89 0.4× 235 1.2× 200 1.0× 152 0.8× 333 1.8× 138 1.6k
Fan Zhang China 19 167 0.7× 177 0.9× 108 0.5× 252 1.3× 183 1.0× 145 1.7k
Joo‐Hee Kim South Korea 22 185 0.8× 220 1.1× 143 0.7× 512 2.7× 197 1.0× 189 1.9k
Danila Azzolina Italy 19 108 0.5× 179 0.9× 243 1.2× 123 0.6× 347 1.8× 171 1.7k
Liyun Ni United States 10 170 0.8× 188 0.9× 346 1.8× 63 0.3× 89 0.5× 20 1.1k
Emilio Perea‐Milla Spain 20 227 1.0× 89 0.4× 219 1.1× 41 0.2× 212 1.1× 60 1.3k

Countries citing papers authored by Mark Corbett

Since Specialization
Citations

This map shows the geographic impact of Mark Corbett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Corbett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Corbett more than expected).

Fields of papers citing papers by Mark Corbett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Corbett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Corbett. The network helps show where Mark Corbett may publish in the future.

Co-authorship network of co-authors of Mark Corbett

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Corbett. A scholar is included among the top collaborators of Mark Corbett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Corbett. Mark Corbett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Walton, Matthew, Mark Corbett, Sarah J Nevitt, et al.. (2025). The cost-effectiveness of enzyme replacement therapies versus best supportive care for treating late onset Pompe disease in the UK NHS. The European Journal of Health Economics.
2.
Kim, Byung Jin, Wei Tan, Teresa Tsakok, et al.. (2023). Systematic review of deep learning image analyses for the diagnosis and monitoring of skin disease. npj Digital Medicine. 6(1). 180–180. 42 indexed citations
3.
Duarte, Ana, Mark Corbett, Hollie Melton, et al.. (2022). EarlyCDT Lung blood test for risk classification of solid pulmonary nodules: systematic review and economic evaluation. Health Technology Assessment. 26(49). 1–184. 6 indexed citations
4.
Drikite, Laura, Mark Corbett, James Doidge, et al.. (2021). Pharmacological and non-pharmacological treatments and outcomes for new-onset atrial fibrillation in ICU patients: the CAFE scoping review and database analyses. Health Technology Assessment. 25(71). 1–174. 4 indexed citations
5.
Duarte, Ana, Simon Walker, Sofia Dias, et al.. (2021). Cost-effectiveness of point-of-care creatinine testing to assess kidney function prior to contrast-enhanced computed tomography imaging. European Journal of Radiology. 142. 109872–109872. 3 indexed citations
6.
Corbett, Mark, Ana Duarte, Alexis Llewellyn, et al.. (2020). Point-of-care creatinine tests to assess kidney function for outpatients requiring contrast-enhanced CT imaging: systematic reviews and economic evaluation. Health Technology Assessment. 24(39). 1–248. 13 indexed citations
7.
Corbett, Mark, David Marshall, Melissa Harden, et al.. (2019). Treating extravasation injuries in infants and young children: a scoping review and survey of UK NHS practice. BMC Pediatrics. 19(1). 6–6. 20 indexed citations
8.
Corbett, Mark, David Marshall, Melissa Harden, et al.. (2018). Treatment of extravasation injuries in infants and young children: a scoping review and survey. Health Technology Assessment. 22(46). 1–112. 20 indexed citations
9.
Corbett, Mark, Mousumi Biswas, Thirimon Moe‐Byrne, et al.. (2017). Certolizumab pegol and secukinumab for treating active psoriatic arthritis following inadequate response to disease-modifying antirheumatic drugs: a systematic review and economic evaluation. Health Technology Assessment. 21(56). 1–326. 32 indexed citations
10.
Woods, Beth, Andrea Manca, Helen Weatherly, et al.. (2017). Cost-effectiveness of adjunct non-pharmacological interventions for osteoarthritis of the knee. PLoS ONE. 12(3). e0172749–e0172749. 56 indexed citations
11.
MacPherson, Hugh, Andrew J. Vickers, Martin Bland, et al.. (2017). Acupuncture for chronic pain and depression in primary care: a programme of research. SHILAP Revista de lepidopterología. 5(3). 1–316. 39 indexed citations
12.
Woolacott, Nerys, Mark Corbett, Julie Jones-Diette, & Robert Hodgson. (2017). Methodological challenges for the evaluation of clinical effectiveness in the context of accelerated regulatory approval: an overview. Journal of Clinical Epidemiology. 90. 108–118. 23 indexed citations
13.
Corbett, Mark, Andrew Webster, Robert D. Hawkins, & Nerys Woolacott. (2017). Innovative regenerative medicines in the EU: a better future in evidence?. BMC Medicine. 15(1). 49–49. 29 indexed citations
14.
Sideris, E.G., Mark Corbett, Stephen Palmer, Nerys Woolacott, & Laura Bojke. (2016). The Clinical and Cost Effectiveness of Apremilast for Treating Active Psoriatic Arthritis: A Critique of the Evidence. PharmacoEconomics. 34(11). 1101–1110. 2 indexed citations
15.
Corbett, Mark, et al.. (2015). Quality Measures and Their Importance to Allergy/Immunology. The Journal of Allergy and Clinical Immunology In Practice. 3(2). 187–191. 2 indexed citations
16.
Corbett, Mark, et al.. (2015). Global Access Programs: A Collaborative Approach for Effective Implementation and Management. Pharmaceutical Medicine. 29(2). 79–85. 1 indexed citations
17.
Corbett, Mark, Stephen Rice, Vichithranie Madurasinghe, et al.. (2013). Acupuncture and other physical treatments for the relief of pain due to osteoarthritis of the knee: network meta-analysis. Osteoarthritis and Cartilage. 21(9). 1290–1298. 132 indexed citations
18.
19.
Cox, Linda, et al.. (2011). Allergen immunotherapy practice in the United States: guidelines, measures, and outcomes. Annals of Allergy Asthma & Immunology. 107(4). 289–299. 46 indexed citations
20.
Burch, Jane, Mark Corbett, Christian Stock, et al.. (2009). Prescription of anti-influenza drugs for healthy adults: a systematic review and meta-analysis. The Lancet Infectious Diseases. 9(9). 537–545. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephen Rice Breakdown of academic impact, for papers by Sun‐Young Jung Breakdown of academic impact, for papers by Marja Blom Breakdown of academic impact, for papers by Alan Oglesby Breakdown of academic impact, for papers by Juan Víctor Ariel Franco Breakdown of academic impact, for papers by Fan Zhang Breakdown of academic impact, for papers by Joo‐Hee Kim Breakdown of academic impact, for papers by Danila Azzolina Breakdown of academic impact, for papers by Liyun Ni Breakdown of academic impact, for papers by Emilio Perea‐Milla
Rankless by CCL
2026